| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Mar 1, 2022 | MANNKIND CORP | Director | Buy | 95.0 | +40,000 | 13.41% | ✗ | $108.4K |
| May 3, 2018 | May 7, 2018 | AMGEN INC | EVP, Global Commercial Ops. | Sell | 40.0 | -883 | -0.41% | ✗ | $149.6K |
| Mar 23, 2018 | Mar 27, 2018 | AMGEN INC | EVP, Global Commercial Ops. | Sell | 17.5 | -8,807 | -4.00% | ✗ | $1.6M |
| Jan 30, 2018 | Feb 1, 2018 | AMGEN INC | EVP, Global Commercial Ops. | Sell | 32.5 | -1,226 | -0.60% | ✗ | $238.4K |